Attention-deficit/hyperactivity disorder (ADHD) is the most common behavioral disorder in childhood with substantial heritability. Pharmacological and molecular genetic studies as well as characterization of animal models have implicated serotonergic dysfunction in the pathophysiology of ADHD. Here, we investigated the effect of polymorphic variants in the gene of the tryptophan hydroxylase-2 (TPH2), the rate-limiting enzyme of serotonin (5-HT) synthesis in the brain, in children and adolescents with ADHD. We analyzed three single nucleotide polymorphisms (SNPs) in and downstream of the transcriptional control region of the TPH2 gene in 103 families with 225 affected children. Allelic association in families with more than one affected child was assessed using the pedigree disequilibrium test. Preferential transmissions were detected for the two SNPs in TPH2's regulatory region (rs4570625, P ¼ 0.049; rs11178997, P ¼ 0.034), but not for the third SNP in intron 2 (rs4565946, P ¼ 0.3517). Haplotype analysis revealed a strong trend of association between the regulatory region SNPs (rs4570625, rs11178997) and ADHD (P ¼ 0.064). Our results link potentially functional TPH2 variations to the pathophysiology of ADHD, and further support the relevance of 5-HT in disorders related to altered motor activity and cognitive processes. Keywords: ADHD; serotonin; TPH2; sib pairs Attention-deficit/hyperactivity disorder (ADHD) is a common syndrome first diagnosed in childhood and frequently persistent throughout adult life. Prevalence ranges between 3 and 9% dependent on the nature of the population sampled and the method of ascertainment.
Attention-deficit/hyperactivity disorder (ADHD) is a common syndrome first diagnosed in childhood and frequently persistent throughout adult life. Prevalence ranges between 3 and 9% dependent on the nature of the population sampled and the method of ascertainment. 1, 2 Although heritability estimates are consistently high, averaging around 0.8, ADHD is a genetically complex disorder characterized by multifactorial inheritance involving numerous genes of moderate effect. [2] [3] [4] [5] While an imbalance in dopaminergic neurotransmission appears to be an important factor predisposing to ADHD, interaction between the dopamine (DA) and serotonin (5-HT) systems has been implicated in both the pathophysiology of ADHD and the mechanism of action of widely used stimulant compounds. By inhibition of the dopamine transporter (DAT), which was reported to be increased in the striatum in ADHD patients, 6 methylphenidate (MPH) is highly effective in reducing the symptoms of ADHD. DAT knockout (KO) mice display a phenotype with increased locomotor activity, 7 which is reversed by MPH-induced increases in 5-HT neurotransmission. 8 On the other hand, the hyperlocomotion in DAT KO mice is attenuated by the selective 5-HT reuptake inhibitor (SSRI) fluoxetine or the 5-HT precursor 5-hydroxytryptophan. 9 Early studies reported low platelet 5-HT levels in ADHD patients 10, 11 and there is an extensive data base that ADHD-specific syndromal dimensions including impulsive behavior, aggressiveness and substance abuse are linked to alterations in central 5-HT activity both in humans and in animal models including nonhuman primates and rodents. [11] [12] [13] [14] [15] According to a recent meta-analysis of molecular genetic studies in ADHD, the association between a length variation of a repeat in the transcriptional control region of the 5-HT transporter gene and ADHD is the third most replicated finding. 16 5-HT 1B receptor KO mice show increased impulsivity and aggressiveness, as well as augmented alcohol and cocaine acquisition. 17 Association between polymorphisms of the 5-HT 1B receptor gene and ADHD has also been observed. 18, 19 These lines of evidence suggest that some of the genetic predisposition to ADHD might be due to variations in genes of the serotonergic pathway.
The conversion of tryptophan to 5-hydroxytryptophan is the first and rate-limiting step in 5-HT synthesis catalyzed by two subtypes of the enzyme tryptophan hydroxylase (TPH1 and 2); 5-HT is then formed by decarboxylation of 5-hydroxytryptophan. The revelation of differential expression of classical TPH1 synthesizing 5-HT in peripheral tissues, and TPH2 synthesizing 5-HT in serotonergic neurons of the midbrain raphe, has shifted interest to the role of brain-specific TPH2 20 in the pathophysiology of various psychiatric disorders, including ADHD. The human TPH2 gene spans approx. 100 kb, consists of 11 exons and is located in the chromosome 12q21.1 region. In order to elucidate the influence of brain 5-HT synthesis on the pathophysiology of ADHD, we investigated transmission of TPH2 alleles and haplotypes in families with affected children.
Methods

Study sample
A total of 225 children with ADHD from 103 families were ascertained and phenotypically characterized by physicians in the Departments of Child and Adolescent Psychiatry of the Universities of Aachen, Lü beck, Marburg, Wü rzburg, and in the Psychiatric Clinic for Children and Adolescents of the District Oberpfalz, Regensburg. Phenotypical assessments were performed either within the respective outpatient units or at the families' homes. Written informed parental consent was obtained for all participants and the study was approved by the ethics committees of the participating university hospitals.
Families were included if they had one or more children affected with ADHD to perform family-based association studies and a genome-wide scan (Hebebrand et al, submitted). The index patient was required to be older than 8 years, and other affected siblings in a family had to be older than 6 years. The lower limit was chosen in order to ensure relative stability/persistence of ADHD symptoms and to exclude children who may show ADHD symptoms during preschool but do not fulfill diagnostic criteria for ADHD during subsequent developmental stages. 21, 22 The mean age of the affected children was 11.4 years (standard deviation, 3.1 years; range, 6.0-20.3 years). The sample included 164 male (72.9%) and 61 female (27.1%) children. All children fulfilled diagnostic criteria for ADHD according to DSM-IV 1 index patients were required to fulfill lifetime criteria for the combined type. ADHD subtypes and psychiatric comorbidities are listed in Table 1 . In five, 77, 18 and three families, one, two, three and four affected children were ascertained, respectively, giving a total of 225 affected children.
In all 103 families, both parents were ascertained and no half-siblings were included. The vast majority of parents were of German origin, and only 12 parents came from other European countries. Based on paternal occupation, the socio-economic status of the families was determined. Two families (1.9%) had high socio-economic status, 66 families (64.1%) had medium and 28 families (27.2%) had low socioeconomic status, and the status of the remaining seven families (6.8%) was not determined. While parents were not subjected to systematic psychiatric assessment, all parents were assessed with the ADHD behavior checklist for adults. 23 According to this self-rating scale, 26% of the mothers and 10% of the fathers showed ADHD scores above the clinical cutoff score.
Exclusion criteria were (a) general IQ r75 as assessed with either the Wechsler Intelligence Scale for Children, 24 ,25 the Kaufman Assessment Battery for Children 26, 27 or the Culture Fair Test, 28 (b) potentially confounding psychiatric diagnoses such as schizophrenia, any pervasive developmental disorder, Tourette's disorder and primary mood or anxiety disorder, (c) neurological disorders such as epilepsy, (d) a history of any acquired brain damage or evidence of the fetal alcohol syndrome, (d) premature deliveries and/or (e) maternal reports of severe prenatal, perinatal or postnatal complications.
Psychiatric classification was based on the Schedule for Affective Disorders and Schizophrenia for School-Age Children Present and Lifetime version (K-SADS-PL). 29, 30 The K-SADS-PL is a highly reliable semi-structured interview used to assess a wide range of psychiatric disorders according to either DSM III-R, 31 DSM-IV 1 or ICD-10. 32 Mothers received (1) the unstructured Introductory Interview, (2) the Diagnostic Screening Interview, (3) the Supplement Completion Checklist and upon fulfillment of screening criteria the appropriate Diagnostic Supplements. The child was interviewed with the screening interview of the K-SADS and in case of positive screening for mood or anxiety disorders with the respective supplements of the K-SADS-PL. The rationale for this dual approach was that internalizing disorders are more reliably assessed by self-reports than by parental ratings, while it turns out to be the other way round for externalizing childhood behavioral disorders. 33 Additionally, we employed the Child Behavior Checklist 34, 35 and a German Teachers' Report on ADHD symptoms; 36 the questions of the latter instrument directly address the DSM-IV items.
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The K-SADS-PL (as based on the maternal interview) was used to assess ADHD both categorically and dimensionally; mothers were asked to report the symptoms applicable to their child in the unmedicated condition. 'Best estimate' diagnoses, which almost completely overlapped with the diagnosis of ADHD in the K-SADS-PL, were determined for all children after individual review of diagnoses, symptoms and impairment level by senior clinicians in regular case conferences of participating clinicians scheduled approximately every 6 months throughout the 2-year ascertainment scheme. We consider our index patients as representative of ADHD patients of German child and adolescent psychiatric units. Clinical characteristics of the patients with ADHD are given in Table 1 .
Thus, 161 of the total of 225 affected offspring were currently or had previously been treated with stimulant medication. In 202 children, ADHD had clinically been diagnosed previously by a child and adolescent psychiatrist (155), a pediatrician (31), a psychologist (13) or other physician (three).
TPH2 genotyping Three single nucleotide polymorphisms (SNPs) found to represent common allelic variants of TPH2 in the general population were chosen for association analyses. All SNPs were listed in the SNP database (dbSNP) of the National Center of Biotechnology Information (NCBI) but had not been verified neither tested for allele frequencies. SNPs rs4570625 and rs11178997 are located in the putative transcriptional control region of TPH2, according to previously published data 37, 38 and our own assessments using an internet-based computational method (URL: http://thr.cit.nih.gov/molbio/proscan). The positions of the SNPs rs4570625 and rs11178997 are À703 and À473 bp upstream of the transcription start site. The SNP rs4565946 is located in intron 2 of TPH2. For genotyping of SNPs, pairs of flanking primers and allele-specific probes were designed as previously described by Mössner et al. 39 Polymerase chain reactions (PCR) were carried out in a 25 ml volume containing 20 ng genomic DNA, 0.4 mM primers, 75 mM Tris-HCl (pH 9.0), 20 mM ammonium sulfate, 0.01% Tween 20, 1.5 mM magnesium chloride, 0.25 mM dNTP and 1 U Taq polymerase. The amplification protocol consisted of 951C for 5 min, followed by 36 cycles of 951C for 45 s, 51.9-56.31C for 45 s and 721C for 45 s. Genotype-based allele frequencies were determined on 116 chromosomes of a sample of unrelated subjects and were found to be 22.4% for the T allele of SNP rs4570625, 5% for the A allele of SNP rs11178997 and 31.0% for the T allele of SNP rs4565946.
For detection of a rare loss-of-function Pro441Arg substitution in TPH2, a 492-bp fragment containing the exon 11 G1463A SNP was amplified by PCR using a modified protocol: 40 50 ng of genomic DNA and control DNA containing one or two copies of the 1463A variant (kindly provided by X Zhang and M Caron) in 75 mM Tris-HCl (pH 9.0), 20 mM ammonium sulfate, 0.01% Tween 20, 1.0 mM magnesium chloride, 0.4 mM of each of the primers, TPH2-1463f (5 0 -atg tgt gaa agc ctt tga ccc aaa gac a) and TPH2-1463r (5 0 -tgc gtt ata tga cat tga ctg aac tgc t), 0.4 mM dNTP and 1 U Taq polymerase. After an initial denaturation step for 5 min at 951C, 40 cycles of denaturing at 951C for 30 s, annealing at 631C for 40 s and extension of 721C for 30 s were performed, followed by a final extension step of 721C for 5 min. PCR products were digested with FokI. The undigested PCR product carries the G variant while the digested product with two fragments of 266 and 236 bp contains the A allele.
Statistical analysis
We checked the three SNPs for Mendelian discrepancies using PedCheck 41 and did not find any inconsistencies. Hardy-Weinberg equilibrium was checked for the markers on parental genotypes by chi-square tests as implemented in Mega2 version 3.0 42 (URL: http://watson.hgen.pitt.edu). We used the pedigree disequilibrium test (PDT) 43, 44 to test for allelic association in these families with more than one affected child and report here P-values for the avePDT statistic, which gives equal weight to all families. For the PDT, nominal P-values are reported, which have to be evaluated against an adequate level of significance. 45, 46 Using a Bonferroni correction of r0.0125 for four SNPs is likely to be too conservative since nearby markers within a gene are predicted to be in linkage disequilibrium (LD). Analysis of LD between the investigated TPH2 polymorphisms and of association of haplotypes in these families was made with the program FAMHAP. 47, 48 This gives D 0 as a measure of LD between pairs of markers and estimates haplotype frequencies from the sample. As an association test proposed by Zhao et al 49 the generalization of the test was used as implemented in FAMHAP. 50 As a correction for multiple testing when analyzing all 50 which results in a global P-value.
Results
To investigate association between TPH2 and ADHD, the PDT was performed for three common TPH2 variants in a sample of 103 families including 225 affected children. Because information that any of the SNPs tested are functional is lacking, association analyses were both single marker and haplotype based. The investigated SNPs were all found to be in significant LD as measured by D 0 , which is standardized for the different allele frequencies of the SNPs (Table 2) . D 0 between rs11178997 and rs4565946 is 1 because the possible haplotype 'AT' was not observed at all in the sample. Genotype distributions in the parental generation did not deviate from HardyWeinberg equilibrium (all P-values 40.1).
Significant preferential transmissions were detected for the two SNPs in TPH2's upstream regulatory region: The G allele of rs4570625 (P ¼ 0.049, twosided) and the T allele of rs11178997 were transmitted more often (P ¼ 0.034, two-sided) to the affected children with ADHD (Table 3) . On the other hand, no transmission distortion of the intronic SNP rs4565946 was observed (P ¼ 0.3517).
The estimated haplotype frequencies (using FAMHAP) of all common haplotypes of the three SNPs are given in Table 4 .
In addition to the observed transmission distortion of SNPs rs4570625 and rs11178997 separately, the haplotypes of both SNPs showed a strong tendency of association (P ¼ 0.064, two-sided) with ADHD, whereas no association was seen in haplotypes comprising the intronic SNP rs4565946 ( Table 5 ). The global P-value corrected for multiple testing for the haplotype analysis of all marker combinations in TPH2 was P ¼ 0.145.
In summary, haplotypes of the alleles of the two SNPs located in the transcriptional control region showed a nearly significant association with ADHD, but are not more strongly associated with ADHD than each single marker alone. The functional 1463A variant in exon 11 of TPH2 was not detected in the index patients of this ADHD sample.
Discussion
The results of the present study link potentially functional TPH2 variants to the pathophysiology of ADHD in a sample of predominantly affected sib pairs, and further support multiple lines of evidence that implicate central 5-HT system dysfunction in disorders characterized by altered motor activity and cognitive processes.
ADHD is a genetically complex disorder and like other neuropsychiatric disorders, such as panic disorder, obsessive compulsive disorder and depression, [51] [52] [53] it is considered to be related to a dysregulation of serotonergic neurotransmission. Conditions of low 5-HT elicited by tryptophan depletion are frequently associated with cognitive impairment. During acute tryptophan depletion, which is an established tool to study the effects of reduced 5-HT, altered cognition (eg recognition, reaction time) occurs in healthy subjects. 54 Likewise, low-dose tryptophan depletion does not affect mood in healthy subjects 55, 56 but changes emotional and cognitive processing in both recovered depressed patients and healthy subjects, thus supporting the view of a Table 4 Estimated frequencies of common haplotypes of TPH2 markers in the sample of 103 ADHD families
Haplotype Frequency Table 5 Family-based association analysis of TPH2 haplotypes in 225 children with ADHD Marker combination tested Two-sided P-value rs4570625-rs11178997 0.064 rs4570625-rs4565946 0.180 rs11178997-rs4565946 0.194 rs4570625-rs11178997-rs4565946 0.178
The global P-value (corrected for multiple testing 42 ) for the haplotype analysis of all marker combinations in TPH2 is 0.145.
TPH2 variations and ADHD S Walitza et al dissociative effect of low 5-HT on affectivity and cognition. 57 The prefrontal cortex, which plays a crucial role in working memory, cognition and control behaviors, displays high densities of inhibitory 5-HT 1A receptors and excitatory 5-HT 2A receptors that are targeted by an extensive network of serotonergic projections from raphe nuclei. 58 Although pyramidal neurons coexpress both receptors, they are mainly inhibited by physiologic amounts of 5-HT. In addition, 5-HT inhibits pyramidal neurons indirectly through activation of 5-HT 2A and 5-HT 3 receptors located on GABAergic interneurons. Finally, frontal lobe involvement is supported by clinical observations of executive-function deficits, including failure to inhibit impulsive actions, difficulty of focusing and sustaining attention, and inability to operate in favor of a remote or abstract reward. [59] [60] [61] There is also evidence that 5-HT system homeostasis influences aggression and violent behavior. 62 Since TPH2 is the rate-limiting enzyme in the biosynthesis of 5-HT in the brain, genetic variation in TPH2 activity is likely to represent a critical factor in the pathogenesis of hyperactivity/hyperlocomotion, attention deficit and impulsivity, the typical symptoms of ADHD.
Evidence for association of TPH2 with depression based on single marker and haplotype analysis of the TPH2 locus spanning approximately 28 kb between exons 5 and 7 was recently observed. 63 Harvey et al Recently, Zhang et al 40 reported a rare G1463A SNP in exon 11 of TPH2 that translates into a Pro441Arg substitution and results in decreased TPH2 activity and consequently lower 5-HT concentrations compared to the wild-type enzyme following expression in PC12 cells. In view of the fact that no carriers of the 1463A variant were found in our sample of patients, it seems unlikely that this functional coding region variant of TPH2 plays a major role in the pathogenesis of ADHD.
Since complex traits as well as disease risk are frequently modulated by functional variants in regions controlling expression or stability of gene transcripts, 66 two polymorphic variants, SNPs rs4570625 and rs11178997, in the upstream regulatory region of TPH2 were selected for analysis in ADHD. We observed transmission disequilibrium for the two potentially functional polymorphisms in the 5 0 regulatory region of TPH2 in a sample of 103 families including 225 children and adolescents with ADHD. Both SNPs are in strong LD and even though they have quite different allele frequencies, their joint consideration in the haplotype analysis does not increase the observed association of each marker separately. A possible reason for this observation could be that one of these two SNPs alone or yet another SNP or set of SNPs in LD with the investigated SNPs is causally involved in the pathogenesis of ADHD. Although the chromosomal locus of TPH2 at 12q21.1 (83 cM on the Marshfield genetic map) is proximal to a previously identified candidate region for susceptibility to ADHD on the long arm of chromosome 12 with a maximum LOD score of 1.5 at 130 cM (12q23), 67 the considerable distance (almost 50 cM) between the two loci renders a contribution of TPH2 variants to the linkage unlikely. A genome scan in our sample of affected ADHD sib pairs almost identical to the sample reported here (Hebebrand et al, manuscript submitted) gave a nonparametric LOD score of 0 in the region of TPH2 (80-85 cM). On chromosome 12, the maximum nonparametric LOD score in this sample was 2.1 at 166 cM. This is so distant from the TPH2 locus that genetic variation at TPH2 is probably not responsible for the observed linkage. Moreover, the high genetic load of ADHD in the families of our cohort may also limit the generalizability to ADHD in the general population. Since 18% of the parents were affected with ADHD based on self-rating scores, the present sample of affected sib pairs may be considered highly 'familial'. As this notion is in accordance with a previous study using affected sib pairs, 68 our patient sample is likely to be more phenotypically homogenous than those ascertained through single ADHD probands.
The transcriptional control region and regulatory elements of TPH2 expression have not yet been studied in detail. Although both SNP rs4570625 and SNP rs11178997 have the potential to affect expression of TPH2 by modifying transcription factor binding sites, elucidation of a functional effect of these SNPs will require detailed biochemical and allele-specific expression studies. Indirect evidence that the potentially functional impact of the two SNP either individually or in concert results in lower enzyme activity is provided by a study in mouse strains exhibiting allelic variation in TPH2 function. Mice carrying a loss-of-function Pro447Arg mutation in Tph2 show significantly increased locomotor activity possibly representing the hyperactivity component of ADHD (V Carola, KP Lesch, C Gross, 2005, unpublished observations).
In conclusion, the present study is the first to evaluate whether variants in the putative transcriptional control region of TPH2 are associated with ADHD. Our findings implicate TPH2 in the pathogenesis of ADHD and suggest TPH2 as a plausible susceptibility gene for ADHD. For extension of these preliminary findings, further investigations are warranted using independent large patient cohorts of 
